Company Active LTD

Company profile

Somnus Scientific Limited

Anaesthesia Propofol Monitoring Devices - Somnus Scientific

Somnus is utilising state-of-the-art biosensor technology to develop its point-of-care sedation and anaesthesia propofol monitoring devices

CRN
11673854
Founded
2018
Age
7

Overview

Legal name
SOMNUS SCIENTIFIC LIMITED
Region
South West England
Registered address
STOCKLAND
BEECHEN CLIFF ROAD
BATH
SOMERSET
UNITED KINGDOM
BA2 4QR
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

21 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

07 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

13 Nov
2018

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2019
Funded years
2019, 2020
Age at first award
0 years

Projects

2020 Feasibility Studies Lead participant

Continuation of UK Project No: 133875 - Real-Time Blood Propofol Monitoring

1 Jun 2020 to 30 Nov 2020

Awarded
£26,490
Total cost £26,490

no public description

2019 Collaborative R&D Lead participant

Real-Time Blood Propofol Monitoring

1 Sep 2019 to 31 Mar 2021

Awarded
£148,896
Total cost £212,708

Propofol is an intravenous drug used to induce general anaesthesia (unconsciousness or drug induced sleep). It can also be administered by continuous infusion to keep the patient asleep and has substantial benefits for patients compared with the use of anaesthetic gases. These benefits include a carefully controlled, smooth induction of anaesthesia and a ...

Product types

Collaborative R&D Feasibility Studies